herO, the world's top-ranked Protoss, enters this GSL Season 2 finals BO7 against Cure with strong recent momentum after capturing the prior season title and demonstrating consistent high-level PvT execution. Cure, a proven Terran contender, brings aggressive macro and timing attack styles that have challenged elite Protoss in past series, including earlier 2026 encounters. Both players arrive with full rosters and no reported injury or scheduling issues, while the best-of-seven format rewards adaptation across maps and builds. Trader consensus reflects herO's edge in form and historical finals experience against top Terran opposition, though Cure's ability to force errors in extended series keeps the matchup competitive.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoherO vs Cure
Moneyline
$21.3K Vol.
Map 1 Winner
$516 Vol.
Map Handicap
$210 Vol.
Total Games
$210 Vol.
This market will resolve to "herO" if herO win the match against Cure.
This market will resolve to "Cure" if Cure win the match against herO.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercato aperto: Jun 7, 2026, 7:00 AM ET
Fonte di risoluzione
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...herO vs Cure
Moneyline
$21.3K Vol.
Map 1 Winner
$516 Vol.
Map Handicap
$210 Vol.
Total Games
$210 Vol.
This market will resolve to "herO" if herO win the match against Cure.
This market will resolve to "Cure" if Cure win the match against herO.
If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.
If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.
If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.
The resolution source for this market will be official information from https://liquipedia.net/starcraft2/Main_Page. However, if https://liquipedia.net/starcraft2/Main_Page has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.
In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.
Mercato aperto: Jun 7, 2026, 7:00 AM ET
Fonte di risoluzione
https://liquipedia.net/starcraft2/Main_PageResolver
0x65070BE91...herO, the world's top-ranked Protoss, enters this GSL Season 2 finals BO7 against Cure with strong recent momentum after capturing the prior season title and demonstrating consistent high-level PvT execution. Cure, a proven Terran contender, brings aggressive macro and timing attack styles that have challenged elite Protoss in past series, including earlier 2026 encounters. Both players arrive with full rosters and no reported injury or scheduling issues, while the best-of-seven format rewards adaptation across maps and builds. Trader consensus reflects herO's edge in form and historical finals experience against top Terran opposition, though Cure's ability to force errors in extended series keeps the matchup competitive.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoFai attenzione ai link esterni.
Fai attenzione ai link esterni.

Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti